SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001171520-16-000902
Filing Date
2016-04-14
Accepted
2016-04-13 19:10:27
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHMARK LESCHLYRHO CAPITAL PARTNERS LLCRHO VENTURES V AFFILIATES, L.L.C.RHO VENTURES V, L.P.RMV V, L.L.C.

Document Format Files

Seq Description Document Type Size
1 eps6767.htm SC 13D/A 156788
  Complete submission text file 0001171520-16-000902.txt   158705
Mailing Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019
Business Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures V, L.P. (Filed by) CIK: 0001325383 (see all company filings)

IRS No.: 201953730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Subject) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88014 | Film No.: 161570167
SIC: 2834 Pharmaceutical Preparations